Insider · CIK 0001303480
John H Tucker
Files at SCPH (scPharmaceuticals Inc.). First filing -, latest -.
In brief
John H Tucker files SEC Form 4 as CEO, president and director at SCPH (scPharmaceuticals Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John H Tucker has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | UTender of shares Common Stock | -122,345 | - | - | 318,502 | Oct 7, 2025 |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | DDisposition to issuer Common Stock | -318,502 | - | - | 0 | Oct 7, 2025 |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -300,000 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -84,500 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -249,000 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -496,674 | $0.00 | $0 | 0 | Oct 7, 2025 |
Questions about John H Tucker
Answered from the filings on this page, as of the latest one.
Is John H Tucker buying or selling?
John H Tucker has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John H Tucker's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John H Tucker has 0.
Where does John H Tucker file Form 4?
John H Tucker has filed Form 4 at SCPH (scPharmaceuticals Inc.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.